DKS CO. LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,240 JPY | -0.31% |
|
-0.61% | +65.22% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company appears to be poorly valued given its net asset value.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company does not generate enough profits, which is an alarming weak point.
- The company benefits from high valuations in earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +65.22% | 203M | - | ||
| +3.28% | 102B | A- | ||
| -2.28% | 65.53B | A- | ||
| +46.19% | 41.76B | B | ||
| +19.68% | 38.66B | B | ||
| +4.90% | 32.28B | A- | ||
| +9.53% | 19.57B | B- | ||
| +15.64% | 16.77B | C+ | ||
| +21.26% | 15.08B | B- | ||
| +11.59% | 14.83B | B |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 4461 Stock
- Ratings DKS Co. Ltd.